18 results with keyword: 'hematopoietic stem cell transplantation a bioethical lens'
Durie et al., “ American society of blood and marrow transplantation, european society of blood and marrow transplantation, blood and marrow transplant clinical trials network,
N/A
Arm 20: Procedure: allogeneic hematopoietic stem cell transplantation Arm 20: Procedure: autologous hematopoietic stem cell transplantation Arm 20: Procedure: peripheral blood stem
N/A
The Acute Leukemia Working Party of European Blood and Marrow Transplant Group; Eurocord-Netcord Regis- try compared outcomes in 682 adults with acute leukemia who received
N/A
A meta-analysis comparing unrelated donor CBT and unrelated donor BM transplantation in adult and pediatric patients found that the risk of chronic GvHD (cGvHD) was
N/A
Allo‑HSCT: allogeneic hematopoietic stem cell transplantation; BM: bone marrow; BMT: BM transplantation; PB: peripheral blood; PBSCT: PB stem cell transplantation;
N/A
Tandem transplantation with an initial round of autologous hematopoietic stem-cell transplantation followed by a non-marrow-ablative conditioning regimen and allogeneic
N/A
Tandem transplantation with an initial round of autologous hematopoietic stem-cell transplantation followed by a non-marrow-ablative conditioning regimen and allogeneic
N/A
LT: liver transplantation; OLT: orthotopic liver transplantation; SBT: small bowel transplantation; KT: kidney transplantation; HTCT: hematopoietic stem cell transplantation;
N/A
Tandem transplantation with an initial round of autologous hematopoietic stem cell transplantation followed by a non-marrow-ablative conditioning regimen and allogeneic
N/A
Tandem transplantation with an initial round of autologous hematopoietic stem-cell transplantation followed by a non-marrow-ablative conditioning regimen and allogeneic
N/A
hemophagocytic lymphohistiocytosis, allogeneic hematopoietic stem cell transplantation, chimerism, veno-occlusive
N/A
EF1a: Elongation factor 1 alpha; HSC: Hematopoietic stem cell; HSCT: Hematopoietic stem cell transplantation; IL2RG: Interleukin 2 receptor subunit gamma; LTR: Long terminal
N/A
Keywords: Bone marrow transplantation, Allogeneic hematopoietic stem cell transplantation, Endocrine complications, Gonadal failure, Hypothyroidism, Osteoporosis,
N/A
Biol Blood Marrow Transplant 15: 523-536 (2009) Ó 2009 American Society for Blood and Marrow Transplantation KEY WORDS: Busulfan, Conditioning regimens, Hematologic
N/A
HSCT ⫽ hematopoietic stem cell transplantation; LIST ⫽ Lupus Immunosuppressive/Immunomodulatory Therapy or Stem Cell Transplant (NCT00230035 at www.clinicaltrials. gov); ASTIS
N/A
Bone marrow transplantation versus prolonged intensive chemotherapy for children with acute lymphoblastic leukemia and an initial bone marrow relapse within 12 months of the
N/A
Regarding cell transplantation, several cell types are potential sources, including hematopoietic stem cells, mesenchymal stem cells, and renal stem/progenitor cells within the
N/A
bone marrow, peripheral blood (usually after mobilization from the bone marrow) and umbilical cord blood] and reinfused into the patient (after being given the potentially
N/A